S18R (p.Ser18Arg) variant of IDS (Iduronate 2-sulfatase)

S18R (p.Ser18Arg) in IDS (Iduronate 2-sulfatase) is a missense change. Clinical records from EBI and UniProt describe it as likely benign. The available variant effect predictions contribute to a CATVariant prioritization score of 0.43 / 1. The record also includes population frequency data and structural context.

S18R (p.Ser18Arg) variant details